Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Sep 22, 2017 | Human | Unknown | Tulathromycin | Injection site pain; Injection site reaction NOS | Ongoing |
| Sep 22, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use | Recovered/Normal |
| Sep 22, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use | Ongoing |
| Sep 21, 2017 | Human | Unknown | Fluralaner Chew Tablets | Rash; Hives (see also 'Skin'); Blistering (see also Application site SOC) | Ongoing |
| Sep 21, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Vials, Leaking | Outcome Unknown |
| Sep 21, 2017 | Human | Unknown | Maropitant Citrate | Taste disorder; Smell disorder NOS; Accidental exposure | Outcome Unknown |
| Sep 21, 2017 | Human | Unknown | Selamectin | Swollen face (see also 'Skin') | Outcome Unknown |
| Sep 20, 2017 | Human | Unknown | Selamectin | Nasal irritation; Odor, Abnormal | Outcome Unknown |
| Sep 20, 2017 | Human | Unknown | Oxytetracycline | Injection site pain; Diarrhoea; Dry mouth; Accidental exposure | Recovered/Normal |
| Sep 20, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Sep 19, 2017 | Human | Unknown | Tulathromycin | Paraesthesia | Recovered/Normal |
| Sep 18, 2017 | Human | Unknown | Fluralaner Chew Tablets | Localised rash | Outcome Unknown |
| Sep 18, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Closure, Abnormal; Containers, Leaking; Dis... | Recovered/Normal |
| Sep 16, 2017 | Human | Unknown | Fluralaner Chew Tablets | Sneezing; Cough | Outcome Unknown |
| Sep 16, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking; Difficulty of Use | Recovered/Normal |
| Sep 15, 2017 | Human | Unknown | Imidacloprid; Moxidectin | Lip erythema; Burning sensation (skin) | Recovered/Normal |
| Sep 12, 2017 | Human | Unknown | Selamectin | Tingling skin; Accidental exposure; Tingling sensation | Outcome Unknown |
| Sep 9, 2017 | Human | Unknown | Itraconazole | Localised skin reaction | Outcome Unknown |
| Sep 8, 2017 | Human | Unknown | Monensin Sodium | Vision blurred; Psychotic disorder; High blood pressure; Decreased heart rate | Ongoing |
| Sep 6, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Sep 6, 2017 | Human | Unknown | Imidacloprid; Moxidectin | Application site numbness; Application site tingling; Application site prurit... | Outcome Unknown |
| Sep 6, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Dispenser, Abnormal; Vials, Leaking | Ongoing |
| Sep 5, 2017 | Human | Unknown | Nitenpyram | Itchy skin; Throat irritation; Stomach cramp; Dry mouth | Ongoing |
| Sep 5, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use | Ongoing |
| Aug 31, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Aug 31, 2017 | Human | Unknown | Oclacitinib Maleate | Intestinal disorder NOS; Flatulence | Outcome Unknown |
| Aug 28, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Aug 28, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site residue; Closure, Abnormal; Dispenser, Abnormal | Recovered/Normal |
| Aug 28, 2017 | Human | Unknown | Tulathromycin | Injection site reaction NOS | Outcome Unknown |
| Aug 25, 2017 | Human | Unknown | Praziquantel; Febantel; Pyrantel | Bad taste; Accidental exposure | Recovered/Normal |
| Aug 25, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Aug 25, 2017 | Human | Unknown | Tildipirosin Injectable | Injection site swelling; Injection site stiffness | Outcome Unknown |
| Aug 25, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Blistering (see also Application site SOC) | Recovered/Normal |
| Aug 25, 2017 | Human | Unknown | Fluralaner Chew Tablets | Bad taste | Ongoing |
| Aug 24, 2017 | Human | Unknown | N-Butylscopolaminium Bromide | Bad taste | Outcome Unknown |
| Aug 23, 2017 | Human | Unknown | Tilmicosin | Shaking; Injection site paraesthesia; Accidental exposure | Recovered/Normal |
| Aug 22, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site reddening; Skin slough; Application site skin discolouration... | Recovered/Normal |
| Aug 21, 2017 | Human | Unknown | Spinosad; Milbemycin Oxime | Localised itching | Ongoing |
| Aug 19, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Aug 19, 2017 | Human | Unknown | Oclacitinib Maleate | Pain NOS; Allergic skin reaction; Hives (see also 'Skin') | Outcome Unknown |
| Aug 19, 2017 | Human | Unknown | Oclacitinib Maleate | Pain NOS; Allergic skin reaction; Hives (see also 'Skin') | Outcome Unknown |
| Aug 18, 2017 | Human | Unknown | Tulathromycin | Injection site pain | Outcome Unknown |
| Aug 17, 2017 | Human | Unknown | Insulin Injectable Vial | Injection site self trauma | Outcome Unknown |
| Aug 17, 2017 | Human | Unknown | Praziquantel; Emodepside | Application site pain; Application site swelling | Outcome Unknown |
| Aug 15, 2017 | Human | Unknown | Ceftiofur Crystalline Free Acid | Injection site swelling; Injection site reaction NOS | Outcome Unknown |
| Aug 14, 2017 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Eye redness; Eye irritation; Vision blurred | Recovered/Normal |
| Aug 14, 2017 | Human | Unknown | Tulathromycin | Injection site lesion | Outcome Unknown |
| Aug 13, 2017 | Human | Unknown | Tulathromycin | Injection site reaction NOS; Injection site irritation | Outcome Unknown |
| Aug 9, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site reaction NOS; Headache | Ongoing |
| Aug 8, 2017 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.